MEDINET Co., Ltd. (2370) Other
Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
| 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Return on Assets | - | - | - | - | -18.2 | -6.7 | -17 | -8.6 | 0.4 | -5 | -5.5 | -4.6 | -6.7 | -5.7 | -5 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 157 | 162 | 158 | 164 | 180 | 170 | 156 | 92 | 76 | 78 | 83 | 96 | 98 | 112 | 107 |